WallStreetZen

NYSE: GSK
Glaxosmithkline Plc Earnings & Revenue

GSK past earnings growth

How has GSK's earnings growth performed historically?
Company
32%
Industry
12.1%
Market
38.02%
GSK's earnings have grown faster (6.72% per year) than the US Drug Manufacturers - General industry average (6.08%)
Performance
GSK's earnings have grown slower (6.72% per year) than the US market average (28.47%)
Performance
GSK's earnings growth is accelerating - its growth over the last year (32%) is above its 5-year compound annual rate (6.72%)
Performance

GSK past revenue growth

How has GSK's revenue growth performed historically?
Company
13.55%
Industry
8.77%
Market
16.24%
GSK's revenue has grown faster (4.39% per year) than the US Drug Manufacturers - General industry average (4.22%)
Performance
GSK's revenue has grown slower (4.39% per year) than the US market average (16.12%)
Performance
GSK's revenue growth is accelerating - its growth over the last year (13.55%) is above its 5-year compound annual rate (4.39%)
Performance

GSK earnings and revenue history

Current Revenue
$44.4B
Current Earnings
$6.1B
Current Profit Margin
13.8%
GSK's has not demonstrated consistent long-term earnings growth over the past 10 years (-29.98%)
Performance

GSK Return on equity

Current Company
61.2%
Current Industry
36.3%
Current Market
14.9%
GSK's Return on Equity (61.2%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

GSK Return on assets

Current Company
6.7%
Current Industry
9.4%
Current Market
6.8%
GSK is generating lower Return on Assets (6.7%) than the US Drug Manufacturers - General industry average (8.26%)
Performance

GSK Return on capital employed

Current Company
11.7%
Current Industry
14.4%
GSK has gotten more efficient at generating Return on Capital (11.7%) compared to 3 years ago (6.3%)
Performance

Glaxosmithkline Earnings & Revenue FAQ

What was GSK's earnings growth in the past year?

As of Q1 2021, Glaxosmithkline's earnings has grown 32% year over year. This is 19.9 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 12.1%. Glaxosmithkline's earnings in the past year totalled $6.11 billion.

What was GSK's revenue growth in the past year?

As of Q1 2021, Glaxosmithkline's revenue has grown 13.55% year over year. This is 4.78 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 8.77%. Glaxosmithkline's revenue in the past year totalled $44.41 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics